Has Pasqal grown their patent portfolio through organic growth or acquisition?
An IPO tells you the share price. It doesn't tell you who really invented what — or why Pasqal's own numbers don't quite add up.
More issues
Something interesting just happened in quantum computing patents
Are we starting to see a more concentrated, IP-intensive group of companies emerge around quantum computing?
Xanadu's focused patent strategy to fault tolerant quantum computing
First pure-play photonic quantum computing company goes public on Nasdaq. Following the public listing, Xanadu will focus on scaling its technology platform and advancing toward quantum computing applications that are useful and available to people everywhere.
Abbott to Acquire Exact Sciences for US$21 Billion — What the Patent Portfolio Reveals
Abbott’s US$21 billion acquisition of Exact Sciences is one of the largest diagnostics deals in recent years. A closer look at Exact Sciences’ patent portfolio offers insight into the technical depth behind the transaction.
Abbott and Exact Sciences confirm acquisition deal
On 20th November 2025, Abbott and Exact
Is Pictiva’s US$191 million win proof of enduring OLED innovation — or of effective IP monetisation?
On 4th November 2025, a Texas jury found that Samsung Electronics had infringed two US OLED patents owned by Pictiva Displays International, a subsidiary of Key Patent Innovations, which invests in and licenses high-value patent portfolios in emerging technology markets.
The Federal Court ordered Samsung to pay US$191.4
Hologic to be acquired by private equity
Hologic, Inc., announced on 21 October 2025 that it has entered into a definitive agreement to be acquired by funds managed by Blackstone and TPG in a transaction valued at up to US$79 per share, representing an enterprise value of up to US$18.3 billion.
Under the terms
Quantum Technology Companies: patent analysis - part III
Background: Quantum computing patent applications have increased significantly since 2009, reflecting the growing maturity and industrial relevance of the field.
Patent intelligence for people who don't read patents
However, for those without a background in patents, or the means to access patent analytics, it’s not always clear
Quantum Technology Companies: patent analysis - part II
Background: Quantum computing patent applications have increased significantly since 2009, reflecting the growing maturity and industrial relevance of the field.
Patent intelligence for people who don't read patents
However, for those without a background in patents, or the means to access patent analytics, it’s not always clear
Quantum Technology Companies: patent analysis
Quantum computing patent applications have increased significantly since 2009, reflecting the growing maturity and industrial relevance of the field.
Patent intelligence for people who don't read patents
However, for those without a background in patents, or the means to access patent analytics, it’s not always clear what
Illumina's acquisition of Somalogic is a clear IP play
Illumina announced on 23 June 2025 that it will acquire SomaLogic from Standard BioTools, for US$350 million cash plus up to US$75 million in performance-based payments, reinforcing its multiomics roadmap by embedding high-plex proteomics into its sequencing operations. The transaction, expected to close in the first half of